Léa Payen Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud Hospices Civils de Lyon Biography Publications Institution JoVE Articles Léa Payen has not added a biography. If you are Léa Payen and would like to personalize this page please email our Author Liaison for assistance. Publications Profiling of Circulating Tumor DNA in Plasma of Non-small Cell Lung Cancer Patients, Monitoring of Epidermal Growth Factor Receptor P.T790M Mutated Allelic Fraction Using Beads, Emulsion, Amplification, and Magnetics Companion Assay and Evaluation in Future Application in Mimicking Circulating Tumor Cells Cancer Medicine. Jul, 2019 | Pubmed ID: 31112372 O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: a Randomized Phase II Study (MGMT-NET) Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 04, 2019 | Pubmed ID: 30824408 Toxicokinetics and Tolerance of a High Energy Material 3,4,5-trinitropyrazole (TNP) in Mice Toxicology and Applied Pharmacology. 09, 2018 | Pubmed ID: 29959026 Metabolomics and Cytotoxicity of Monomethylhydrazine (MMH) and (E)-1,1,4,4-tetramethyl-2-tetrazene (TMTZ), Two Liquid Propellants Toxicology in Vitro : an International Journal Published in Association with BIBRA. Oct, 2018 | Pubmed ID: 29885439 Cross-platform Comparison for the Detection of RAS Mutations in CfDNA (ddPCR Biorad Detection Assay, BEAMing Assay, and NGS Strategy) Oncotarget. Apr, 2018 | Pubmed ID: 29765524 Evaluation of Pre-analytical Conditions and Comparison of the Performance of Several Digital PCR Assays for the Detection of Major Mutations in Circulating DNA from Non-small Cell Lung Cancers: the CIRCAN_0 Study Oncotarget. Oct, 2017 | Pubmed ID: 29152135 Destabilization of the TWIST1/E12 Complex Dimerization Following the R154P Point-mutation of TWIST1: an in Silico Approach BMC Structural Biology. 05, 2017 | Pubmed ID: 28521820 (E)-1,1,4,4-Tetramethyl-2-tetrazene (TMTZ): A Prospective Alternative to Hydrazines in Rocket Propulsion Chemistry (Weinheim an Der Bergstrasse, Germany). Jul, 2017 | Pubmed ID: 28498558 Pharmacokinetic Interactions in Mice Between Irinotecan and MBL-II-141, an ABCG2 Inhibitor Biopharmaceutics & Drug Disposition. Jul, 2017 | Pubmed ID: 28207160 The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells Neoplasia (New York, N.Y.). 05, 2016 | Pubmed ID: 27237323 Deciphering the Molecular Mechanisms Underlying the Binding of the TWIST1/E12 Complex to Regulatory E-box Sequences Nucleic Acids Research. 06, 2016 | Pubmed ID: 27151200 Lysyl Oxidase Family Activity Promotes Resistance of Pancreatic Ductal Adenocarcinoma to Chemotherapy by Limiting the Intratumoral Anticancer Drug Distribution Oncotarget. May, 2016 | Pubmed ID: 27050073 Quantification and Kinetic Study in Plasma and Tissues of (E)-1,1,4,4-tetramethyl-2-tetrazene, a Liquid Propellant and a Transformation Product of 1,1-dimethyl Hydrazine Analytical and Bioanalytical Chemistry. Sep, 2015 | Pubmed ID: 26082396 Quantification of β-aminopropionitrile, an Inhibitor of Lysyl Oxidase Activity, in Plasma and Tumor of Mice by Liquid Chromatography Tandem Mass Spectrometry Biomedical Chromatography : BMC. Jul, 2014 | Pubmed ID: 24424787 Simultaneous Quantification of 5-FU, 5-FUrd, 5-FdUrd, 5-FdUMP, DUMP and TMP in Cultured Cell Models by LC-MS/MS Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. Oct, 2009 | Pubmed ID: 19620028 Semi-automatisk PD-L1 karakterisering og opplisting av sirkulerende tumor celler fra ikke-liten celle Lungekreftpasienter ved Immunofluorescence Jessica Garcia1,2,3, David Barthelemy1,2,3, Florence Geiguer1,2, Julie Ballandier1,2,3, Kathryn W. Li4, Jean-Phillippe Aurel4, Frédérique Le Breton5, Claire Rodriguez-Lafrasse1, Brigitte Manship3, Sébastien Couraud6,7, Léa Payen1,2,3 1Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 2Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 3University of Lyon, Claude Bernard University, Cancer Research Center of Lyon, 4Biolidics Limited, 5Institut de Pathologie Multisites des HCL-Site Sud, Hospices Civils de Lyon, 6Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, 7EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, Lyon 1 University JoVE 59873 Cancer Research
Semi-automatisk PD-L1 karakterisering og opplisting av sirkulerende tumor celler fra ikke-liten celle Lungekreftpasienter ved Immunofluorescence Jessica Garcia1,2,3, David Barthelemy1,2,3, Florence Geiguer1,2, Julie Ballandier1,2,3, Kathryn W. Li4, Jean-Phillippe Aurel4, Frédérique Le Breton5, Claire Rodriguez-Lafrasse1, Brigitte Manship3, Sébastien Couraud6,7, Léa Payen1,2,3 1Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 2Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 3University of Lyon, Claude Bernard University, Cancer Research Center of Lyon, 4Biolidics Limited, 5Institut de Pathologie Multisites des HCL-Site Sud, Hospices Civils de Lyon, 6Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, 7EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, Lyon 1 University JoVE 59873 Cancer Research